在心力衰竭中使用组合利尿剂
Joan Carles Trullàs1,2, Jesús Casado3, Marta Cobo-Marcos4
1Internal Medicine Department, Hospital d'Olot I Comarcal de La Garrotxa, Avinguda Dels Països Catalans 86, 17800, Olot, Girona, Spain. jctv5153@comg.cat.
Current heart failure reports
|April 8, 2024
概括
结合利尿剂可以帮助管理心力衰竭 (HF) 拥堵,即使在治疗的早期. 这种方法有望克服利尿剂耐药性并改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 利尿剂对于治疗急性心力衰竭 (HF) 和充血是必不可少的.
- 慢性循环利尿剂的使用可以导致由于脏重塑而导致利尿剂耐药性.
研究的目的:
- 审查目前针对高血压拥堵的药理疗法,重点关注组合性利尿剂策略.
- 提供一种实用的方法来管理HF患者的尿素耐药性.
主要方法:
- 整合最近的研究数据.
- 专注于临床试验和观察性研究的证据.
主要成果:
- 联合利尿剂治疗可以在不增加循环利尿剂剂量的情况下提前开始.
- 最近的试验表明,联合利尿剂治疗具有足够的安全性.
- 利尿组合是一种有前途的策略,以克服高频率患者的利尿耐药性.
结论:
- 结合性利尿疗法提供了一种可行的方法来管理高频率患者的堵塞和利尿抗性.
- 需要进一步的研究来阐明抗利尿剂的病理生理学,并确认长期的安全性和有效性.
相关概念视频
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Antihypertensive Drugs: Potassium-Sparing Diuretics
531
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
531
Antihypertensive Drugs: Thiazide-Class Diuretics
620
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
620
Antihypertensive Drugs: Action of Diuretics
679
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
679
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337


